What does stable disease mean on my Breast Cancer scan results

Breast CancerMay 17, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding "Stable Disease" on Your Breast Cancer Scan

Great question—this is an important term to understand, and I'm glad you're asking about it.

What "Stable Disease" Means

Stable disease means that your cancer has not grown and has not shrunk since your last scan. The tumors are essentially the same size they were before. It's a middle ground between two other response categories:

  • Complete response = No visible cancer remaining
  • Partial response = Cancer has shrunk by at least 30%
  • Stable disease = Cancer size unchanged (within measurement limits)
  • Progressive disease = Cancer has grown

Why This Matters for Your Treatment

According to NCCN Guidelines for Metastatic Breast Cancer, stable disease is an important finding because it tells your oncology team:

  1. Your current treatment is working to control the cancer — even though it's not shrinking it, the treatment is preventing it from growing
  2. You may continue your current treatment plan — your doctor will likely recommend staying on the same therapy
  3. Your disease is not progressing — this is clinically meaningful and often considered a positive outcome

Important Context

As noted in cancer treatment discussions, stable disease represents a valuable clinical outcome. While patients and doctors naturally hope for shrinkage (partial or complete response), stopping cancer growth is a significant achievement. Many patients live well with stable disease for extended periods while on treatment.

Questions to Ask Your Oncologist

Since you have stable disease on your scan, here are specific questions to discuss with your care team:

  1. "Does this mean I should continue my current treatment plan?"
  2. "How often will we repeat imaging to monitor for changes?"
  3. "What would prompt a change in my treatment—would growth of a certain amount trigger a switch?"
  4. "Are there any new treatment options I should know about, or are we staying the course?"
  5. "What symptoms or changes should I report between scans?"

Next Steps

According to NCCN Guidelines, patients with stable disease typically continue on their current therapy with regular imaging follow-up (usually every 6-12 weeks depending on your specific situation). Your care team will monitor you closely to catch any changes early.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: